Medical Gastroenterology is integral to the Nottingham Digestive Diseases Centre. We employ a broad range of research methodologies. We have experts in basic and translational research who use cutting-edge molecular biological, cell biological and microbiological techniques. We have a leading therapeutics programme, focussing recently on development of safe non-steroidal anti-inflammatory drugs and on the chemotherapeutic potential of these and related compounds. We have a large basic and clinical research programme in inflammatory bowel disease. We are particularly interested in chemotherapeutic approaches to prevent GI cancers and in developing rational screening and surveillance programmes. Recently we have started a large programme of GI stem cell research. Finally, we have a major interest in hepatology, in particular in hepatitis C infection, the new disease of non-alcoholic fatty liver and the effects of drugs on the liver. The University of Nottingham is consistently named as one of the most targeted universities by Britain's leading graduate employers and can offer students a head-start when it comes to their career.